Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is well-positioned to address the challenges in healthcare delivery with its integrated platform that targets access to care, affordability,and improved patient health outcomes. The company's positive outlook is based on its steady margin improvement plan, as well as its resilient businessmodel, which is backed by a diverse and growing customer base. While facing competition from both smaller and larger players in the market, Phreesia'sstrong regulatory compliance, focus on privacy and security, and potential for further optimization make it a strong contender in the healthcare industry.

Bears say

Phreesia is facing multiple challenges that may hinder its growth potential. The company's focus on ROI may limit price increases, leading to slower revenue growth. Additionally, while Phreesia has made efforts to improve its patient authorization experience, there are still instances where the company does not have permission for healthcare content, resulting in lost revenue opportunities. In terms of costs, Phreesia has made significant investments in launching an HCP product and acquiring AccessOne, which may not generate immediate returns. Furthermore, the recent restructuring efforts may not be enough to offset uncertainties on back-half Network Solutions commitments, resulting in lower-than-expected revenue and potential margin pressures. Overall, these factors may negatively impact Phreesia's financial performance and limit potential for significant value creation for investors.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.